A controversial hepatitis B vaccine trial on newborns was given approval to move forward in Guinea-Bissau last week, according to a report from the Guardian. The US-backed study will involve 14,000 babies in Guinea-Bissau. Danish researchers plan to withhold the vaccine from half of the newborns for the first six weeks of life. The 1.6-million-dollar…